MedPath
NMPA Approval

Atosiban Acetate Injection

国药准字H20193285

September 26, 2019

Drug Information

醋酸阿托西班注射液

注射剂

5ml:37.5mg(按C43H67N11O12S2计)

化学药品

September 26, 2019

Company Information

Applicant Company

广州高新技术产业开发区广州科学城香山路31号

Manufacturing Company

广州高新技术产业开发区广州科学城香山路31号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

醋酸阿托西班注射液 - NMPA 批准文号 | MedPath